BT-75

N/A

Report date: 2025/01/26 18:33:14
NME

Base Information

Drug NameBT-75
Drug Alias NameRAR alpha agonist (Nathan Kline Institute for Psychiatric Research/Long Island university/New York University School of Medicine/Icahn School of Medicine at Mount Sinai)retinoic acid receptor alpha agonist (Nathan Kline Institute for Psychiatric Research/Long Island university/New York University School of Medicine/Icahn School of Medicine at Mount Sinai)BT-75
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor alpha agonists
TargetsRetinoic acid receptor alpha
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNathan Kline Institute For Psychiatric Research
China Registration ClassN/A

Develop Information

Active CompaniesMount Sinai Medical Center/Miami Jewish Home Andhospital For Theed Home HealthencyLong Island UniversityNew York University School Of Medicine +[4] 
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A